Stability testing showed non-compliance in active substance release after 30 minutes, which may affect the product’s effectiveness and poses a real risk to patient health due to potential lack of efficacy. Potential effects: treatment failure, risk of infection progression.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batches 10421 and 10421A, check the batch numbers on the packaging and return the product to the pharmacy; if there are concerns about the effectiveness of past treatment, ...
The Chief Pharmaceutical Inspector withdrew batches 10421 and 10421A of Linezolid Polpharma 600 mg from the national market, prohibited their placing on the market, and granted the decision immediate ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ